subscribeSubscribe
price-trendAsk Us
Mylan`s Generic Epoprostenol Sodium Receives Approval in US

Mylan`s Generic Epoprostenol Sodium Receives Approval in US
FDA
12 Jun 2024
Share Share
Teva`s troubled plant seen to create injectable drug shortages

Teva`s troubled plant seen to create injectable drug shortages
Joseph Keenan FIERCEPHARMA
24 May 2022
Share Share
Enforcement Report - Week of August 25, 2021

Enforcement Report - Week of August 25, 2021
FDA
25 Aug 2021
Share Share
Enforcement Report - Week of March 3, 2021

Enforcement Report - Week of March 3, 2021
FDA
03 Mar 2021
Share Share
Sun Pharm`s Generic Epoprostenol Sodium Receives Tentative Approval In US

Sun Pharm`s Generic Epoprostenol Sodium Receives Tentative Approval In US
FDA
21 Jan 2021
Share Share
J&J unit to pay $360 million to U.S. to resolve charity kickback probe

J&J unit to pay $360 million to U.S. to resolve charity kickback probe
Nate Raymond REUTERS
07 Dec 2018
Share Share
FDA Confirms Paragraph IV Patent Challenge of Veletri (Epoprostenol Sodium) Injection

FDA Confirms Paragraph IV Patent Challenge of Veletri (Epoprostenol Sodium) Injection
FDA
27 Dec 2017
Share Share
Drug Recall: Flolan (2015-03-20)

Drug Recall: Flolan (2015-03-20)
HEALTHY CANADIANS
25 Mar 2015
Share Share
United Therapeutics Announces Signing of Agreement for New Remodulin Delivery System

United Therapeutics Announces Signing of Agreement for New Remodulin Delivery System
Press Release UNITED THERAPEUTICS CORPORATION
31 Dec 2014
Share Share